|
This communication is based on guidance from Group Health
The centrally managed COVID-19 contact tracing program for US bp offices will be discontinued as of June 1, 2022. This applies to our US bp offices, not including operational sites, which manage their own contact tracing processes locally. Group Health guidance should continue to be followed for any COVID-19 positive cases or close contacts as stated below.
This change aligns with the discontinuation of the COVID-19 case notification process, which is also discontinued as of May 31, 2022.
Should characteristics of the COVID-19 virus change, the centrally managed contact tracing program will be reviewed and may be reinstated. Anyone coming to a bp office should continue to self-monitor regularly for symptoms of COVID-19 and remain offsite if symptomatic.
If ill or displaying symptoms, inform your line manager and follow the published bp guidance here: covid-19-health-decision-tree-for-businesses.pdf (sharepoint.com) as well as the US office recommendations summarized below:
More information on COVID-19 can be found on the OneBP - “Health & Wellbeing” site here.
Of course, all employees and guests are welcome to continue wearing a mask in the office if they choose – and no one should question that choice. In alignment with bp’s values and behaviors, we must treat all employees with respect. If you have questions about the process, please contact me at keith.botley@bp.com.
Group Health |